Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687102 · ClinicalTrials.gov registry record · Phase 3
Cognition in the Study of Tamoxifen and Raloxifene
A Phase 3 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,498
- Enrollment target
NCT00687102 is a Phase 3 study that has completed, run by Wake Forest University. The registered enrollment target is 1,498 participants.
The verdict
NCT00687102, a Phase 3 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,498 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.
Interventions
- DRUG raloxifene
- DRUG tamoxifen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,498 participants |
| Start Date | 2001-10 |
| Est. Completion | 2008-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00687102
The ClinicalTrials.gov registry entry for NCT00687102 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,498 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which raloxifene is the first listed.
NCT00687102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00687102 about?
NCT00687102 is a clinical study titled "Cognition in the Study of Tamoxifen and Raloxifene". The purpose of this study is to assess the effects of tamoxifen and raloxifene on cognitive aging in selected cognitively-healthy women.
What is the current status of trial NCT00687102?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,498 participants. The study started on 2001-10. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00687102?
The interventions under investigation include: raloxifene (DRUG), tamoxifen (DRUG).
Who is sponsoring clinical trial NCT00687102?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.